Estudo randomizado SILENCE | Em pacientes em fim de vida, o butilbrometo de escopolamina subcutâneo profilático reduz a ocorrência de estertor da morte (respiração ruidosa causada pelo muco presente no trato respiratório superior).
8 Out, 2021 | 11:12hEffect of Prophylactic Subcutaneous Scopolamine Butylbromide on Death Rattle in Patients at the End of LifeThe SILENCE Randomized Clinical Trial – JAMA (gratuito por tempo limitado)
Editorial: Preventing Death Rattle With Prophylactic Subcutaneous Scopolamine Butylbromide – JAMA (gratuito por tempo limitado)
Entrevista com os autores: Scopolamine Butylbromide for Preventing End-of-Life Death Rattle – JAMA
Comentário no Twitter
In a randomized clinical trial among patients near the end of life, prophylactic subcutaneous scopolamine butylbromide significantly reduced the occurrence of death rattle https://t.co/e6BDI5yirY pic.twitter.com/hHfhC2iYHh
— JAMA (@JAMA_current) October 5, 2021